Member Info for TrekMadone

The price of shares in AIM-listed immunodiagnostics specialist Oncimmune (LON:ONC) dropped by 8.90% to 161.70p (as of 15:10 GMT) after its pre-tax loss for the year ended 31st May broadened. Revenues grew significantly and further major agreements have been reached since the end of the period, but costs are still significantly above income.

CEO Dr Adam Hill commented: “We have made strong progress in our first full year of trading since the launch of our three-year strategy in September 2018, which has delivered a step-change in our revenue growth over the year led by the ImmunoINSIGHTS services business. Despite the impact of COVID-19, further positive news flow post year end has sustained the Group’s growth trajectory throughout H1 2021.

“Following the successful turnaround, Oncimmune now has a solid platform business underpinned by its core technology and expertise, that is validated by an expanding stable of commercial contracts and a full pipeline of pharma service opportunities. This underpins our expectation of delivering substantial further growth in the re-focused business throughout FY 2021 and beyond, about which the Company looks forward to providing further progress updates“.

https://masterinvestor.co.uk/financial-news/oncimmune-losses-drive-down-shares/?mc_cid=2eb1a06410&mc_eid=418bda054f

Trek

Open Orphan (ORPH), the fast growing pharma services at the heart of the COVID-19 battle rose another 5%. Having signed a significant contract with the UK Government earlier in the month, the company was at it again, revealing a new 2 year contract with a tier 1 German pharmaceutical group. The deal to be executed via Open Orphan’s Venn Life Science subsidiary was said by Executive Chairman Cathal Friel to demonstrate Venn’s position as a market leader in its field.

Plus nice newspaper screenshot!

https://www.share-talk.com/stock-market-watch-amc-mtl-char-orph-tern/?utm_source=mailpoet&utm_medium=email&utm_campaign=the-last-newsletter-total-posts-from-our-blog_2#gs.jmzcxo

Trek

You can register here....

https://*********************/events/sharesoc/sharesoc-webinar-with-synairgen-sng-18-november-2020/201

Trek

Milk,

We don’t know. My earlier post on DTR explains that the info we seek can be legitimately withheld.

Wind it forward...I sold my AVCT shares and the sp rocketed can I have my money back? DTR says no!

The sovereign deal means all eventualities under exceptional circumstances are covered.

Trek

There’s been no tech transfer. There’s been no figures from Porton Down re Avacta. There’s been nothing from Liverpool. There’s been nothing on BAMS. There’s been nothing on intent to explore other markets other than UK. There’s been nothing on Medusa other than the clarity of antibody.

There has only been radio silence. Now if you look through the material disclosure rules DTR. 5.2. there are provisions for these scenarios.

There are also numerous wartime acts that can be applied to pandemic situations from commandeering cruise ships to businesses. These are valid and easy to find.

DTR....

Delaying disclosure .....................................................................................................
[deleted]
[article 17(4), (5) and (8) of the Market Abuse Regulation]
Issuers should be aware that ESMA has issued guidelines under article 17(11) of the Market Abuse Regulation which contain a non-exhaustive indicative list of the legitimate interests of issuers to delay disclosure of inside information and situations in which delayed disclosure is likely to mislead the public. The ESMA MAR delayed disclosure guidelines are available here: https://www.esma.europa.eu/sites/default/files/library/2016-1478_mar_ guidelines_-_legitimate_interests.pdf.
Legitimate interests and when delay will not mislead the public .....................................................................................................
(1) Delaying disclosure of inside information will not always mislead the public, although a developing situation should be monitored so that if circumstances change an immediate disclosure can be made.
(2) Investors understand that some information must be kept confidential until developments are at a stage when an announcement can be made without prejudicing the legitimate interests of the issuer.

https://www.handbook.fca.org.uk/handbook/DTR.pdf
.........

So basically you have a legal justification for ‘radio silence’ that could mean that many of the objectives in my first paragraph have been concluded!

Fact is we don’t know the facts!

Trek

Looking at all those charts that the BBC couldn’t even be arsed to get in frame even after all the delays! Absolutely rubbish!

Then to work out that they told a story about prevention only to be presented by two scientists with a stat pack and no scientific solutions or treatments other than isolation as a short term fix!!.

Well I thought it was appalling. They basically said we’ve learnt loads and wave 2 is gonna be worse than wave 1. So now I’m think what is gonna stop wave 3 being worse than wave 2 as they have offered nothing that hasn’t been tried before to break the chain.

I don’t like to criticise without offering an alternative but surely an OPEN LABEL PHASE THREE TRIAL OF SNG001 would ameliorate the bed crisis!

Trek....exasperated!!

‘No one will be ramming a swab in their brains at home.’

Well they do, my niece has just had an at home nasal test. Followed by near vomiting!

The more appropriate point is once tried never again! Step up saliva!

Trek

Ps. Yet again an earlier thread disappeared, my iAbra email, ‘turnstile test’ was only for info and had no personal details. It’s not a direct threat to Avacta and can be viewed on the TTG bb if anyone wishes.

Trek

From BBC news....

‘Testing capacity is being increased. In the coming days the government is expected to announce its labs are able to process 500,000 tests a day. That should allow the system to speed up turnaround times.’

That’s an implication of BAMS.

What if the nomad discussion with Al went along the lines of I really like this house, but I know this price inflection and am aware of imminent newsflow. Quite possible the nomad advised he sell before the news to clinche the deal rather than become a media covid millionaire target.

Some people may not get it but enough money quantifiable by the individual is exactly that. It enough and a house, the house can mean more happiness than an extra zero on a spreadsheet.

But then again I could be way off the mark, after all it’s just BB shared chat.

Trek

‘The army in a few days?’

Trek

It’s always been on the cards here. A bid only needs to be at the year high sp with 30% holding to kick off. Obviously it then needs a majority vote. A quid would be a rip off. Trek kicking and screaming won’t matter a jot!

Trek

According to process a decision is due 25days from submission for small medium or large scale applications.

http://www.epa.gov.gh/epa/regulations

Can anyone find a link or an RNS even of recently authorised permits so we can see how long they currently take. I haven’t been successful on the govt sites.

Trek

That’s the reason, unfortunately, to buy here. It’s akin to a second chance at backing covid stocks and this time AVCT are more advanced.

My personal timeline was to have sold by now. However, the 2nd wave and the likelihood of lockdowns and probably a third wave because unless they do something dramatically different the reasons for a second wave would not have changed.

Unfortunately it’s a lifeline to the SP’s of the likes of AVCT and SNG. Hence, one adjusts one’s investment timeline accordingly.

I know it’s axiomatic as had the virus fizzled out these solutions would not be needed in such immediate quantity. Nonetheless, they now have a chance to catch up.

Trek

Hi Gilers1,

I also have a decent position here and will be adding again soon. However, just for transparency, be warned that you may find that you cannot sell anything significant in a hurry. I often run dummy buy/sell trades to understand liquidity and it’s often been a nightmare to buy or sell here.

It’s another reason why one has to get in early so you can derisk into news while there are buyers. I traded this in the 120’s to grab a few extra. It wasn’t worth the effort!

Atb

Trek

I don’t like to cross BB but I am invested in WSBN and here. The abilities of the bods in many of these companies varies considerably. With Poulden at WSBN you can add Lenigas (the finder) into the mix. You can go to KAT or KIBO and say the same about LC. You can look at the delivery of MB at THR and you see a pattern of shortcomings but the directors always do alright. Same at BPC in O&G. But of all of those people just once they may be getting lucky. It’s how it goes, failure, let downs and then success or often they stumble on the deal. The list of examples is endless. I could go on. If it helps I don’t trust any of them. Even here! I DMOR and spread my risks.

However, a change of fortune could be what’s about to happen at WSBN with Havieron/Telford, with KAT at Blyvoor, with THR at Ragged range or even with BPC at long last in the Bahamas. It’s all part of investing.

Place your bets, but never the house!

Trek

Hi Gilers1.

Yes loss has widened but rev’s are increasing. cost increases are accretive and R&D related. Numbers can be spun either way. I know that. IMO these are not lipstick on a pig figures. They have currency behind them. It’s normal growth.

As for the market being short sighted. Well, that is difficult to tell. Volumes don’t indicate a sell off and this is a volatile stock. I watched it drop 12p on a 3k trade this week and then recover. Today has been far from a sell off. The biggest trade was TNCP, 30k and it was a duplicate trade. Probably just moved across books as MM’s don’t have stock.

https://api.londonstockexchange.com/api/gw/lse/download/ONC/trades

I get the profit taking but for me that time is not yet. There’s plenty of legs in this one. The newsflow has been excellent, the numbers on contracts even if just guidance can defo be improved though. The big Pharma companies check out the finances of any company before they enter into a contract. And for ONC to be discussing acquisitions they have the fundamentals in place to even contemplate that.

Usual caveats

Trek

Absolutely. I have been here many times before and it’s the time to be here at ground level. Don’t forget we’ve motored from 60p to here. There’s bound to be profit taking.

I missed the call, had to go out but will listen later.

I sold other stocks to add to my position here and still think that that’s the right call and will be adding again.

Director options are 200p. Sp is illiquid so moves on low volume. A 10-20% swing is not a lot and can bounce back easily. TA still bullish as well. Not many companies winning contracts hand over fist atm!

Trek

Yep was a very good interview. One key point was that the finances were covered off from any and every angle, the CLN facility was explained as expected.

Now just for my finances. How do I get all those BPC shares into my ISA before lift off! Ah well a nice problem to have in these dire times and I am going to set aside a number of shares for a charity ride. Nothing heroic, just a small percentage to be sold if we strike. Sleep with a conscience and all that.

Nice w/e all, gonna be some ride here now!

Trek

Big if profit taking. I think we’ll see some director buys now out of close period.

Regular income, contracts landed risk to upside from here.

Trek

“These 18 holes are planned to increase the definition and extent of the known Barns JORC resource, which currently stands at 104,000 ounces using a 0.5g/t gold cut-off grade, as well as to test a thesis that there may be a possible connection between the Barns deposit and the White Tank deposit”

So we may soon have increased JORC on Barns + two connected deposits.

Getting that extra drill was quite a feat in this mini rush!

Trek

I have just read through THR report. 2.4 quarters cash. Different horses/different courses and they will need to raise soon but the point is the market is not valuing just how much headroom CCZ has. They can accelerate the program and still have cash. 6.9 quarters in this market is exceptional.

Sometimes it can be other factors like the MM managing the float. If they pop the price they can be stuck as people buy. If I didn’t already hold here I’d be a buyer. Finance tick, postcode tick, Cu price tick; which makes for potentially huge upside from this mcap.

Trek